Royal Bank of Canada’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19M | Sell |
47,360
-7,695
| -14% | -$182K | ﹤0.01% | 3496 |
|
|
2025
Q4 | $1.45M | Sell |
55,055
-2,870
| -5% | -$62.6K | ﹤0.01% | 3368 |
|
|
2025
Q3 | $989K | Sell |
57,925
-15,058
| -21% | -$216K | ﹤0.01% | 4000 |
|
|
2025
Q2 | $915K | Buy |
72,983
+16,212
| +29% | +$193K | ﹤0.01% | 3970 |
|
|
2025
Q1 | $676K | Sell |
56,771
-4,155
| -7% | -$56.7K | ﹤0.01% | 3769 |
|
|
2024
Q4 | $893K | Sell |
60,926
-952
| -2% | -$13.3K | ﹤0.01% | 3641 |
|
|
2024
Q3 | $776K | Sell |
61,878
-3,750
| -6% | -$40.8K | ﹤0.01% | 3742 |
|
|
2024
Q2 | $559K | Sell |
65,628
-3,386
| -5% | -$30.1K | ﹤0.01% | 3930 |
|
|
2024
Q1 | $726K | Sell |
69,014
-16,173
| -19% | -$180K | ﹤0.01% | 3706 |
|
|
2023
Q4 | $885K | Buy |
85,187
+3,433
| +4% | +$27.4K | ﹤0.01% | 3765 |
|
|
2023
Q3 | $518K | Sell |
81,754
-38,781
| -32% | -$286K | ﹤0.01% | 4006 |
|
|
2023
Q2 | $1.04M | Sell |
120,535
-50,844
| -30% | -$455K | ﹤0.01% | 3344 |
|
|
2023
Q1 | $1.55M | Buy |
171,379
+2,962
| +2% | +$25.8K | ﹤0.01% | 3008 |
|
|
2022
Q4 | $1.32M | Buy |
168,417
+134,535
| +397% | +$945K | ﹤0.01% | 3267 |
|
|
2022
Q3 | $208K | Buy |
+33,882
| New | +$204K | ﹤0.01% | 4743 |
|
|
2022
Q1 | – | Sell |
-18,763
| Closed | -$307K | – | 8077 |
|
|
2021
Q4 | $307K | Sell |
18,763
-1,170
| -6% | -$24.4K | ﹤0.01% | 4907 |
|
|
2021
Q3 | $579K | Buy |
19,933
+1,409
| +8% | +$46.8K | ﹤0.01% | 4218 |
|
|
2021
Q2 | $643K | Sell |
18,524
-1,618
| -8% | -$51.3K | ﹤0.01% | 4049 |
|
|
2021
Q1 | $636K | Sell |
20,142
-18,860
| -48% | -$766K | ﹤0.01% | 3971 |
|
|
2020
Q4 | $1.84M | Buy |
39,002
+10,629
| +37% | +$494K | ﹤0.01% | 2987 |
|
|
2020
Q3 | $1.32M | Buy |
28,373
+20,892
| +279% | +$717K | ﹤0.01% | 3021 |
|
|
2020
Q2 | $269K | Sell |
7,481
-3,487
| -32% | -$128K | ﹤0.01% | 4230 |
|
|
2020
Q1 | $390K | Sell |
10,968
-2,344
| -18% | -$95.9K | ﹤0.01% | 3829 |
|
|
2019
Q4 | $605K | Buy |
13,312
+1,068
| +9% | +$38.8K | ﹤0.01% | 3841 |
|
|
2019
Q3 | $303K | Sell |
12,244
-828
| -6% | -$20.7K | ﹤0.01% | 4175 |
|
|
2019
Q2 | $287K | Buy |
13,072
+835
| +7% | +$15.3K | ﹤0.01% | 4241 |
|
|
2019
Q1 | $198K | Buy |
12,237
+4,387
| +56% | +$68K | ﹤0.01% | 4361 |
|
|
2018
Q4 | $115K | Sell |
7,850
-1,564
| -17% | -$20.5K | ﹤0.01% | 4652 |
|
|
2018
Q3 | $148K | Sell |
9,414
-6,513
| -41% | -$93.2K | ﹤0.01% | 4653 |
|
|
2018
Q2 | $235K | Buy |
15,927
+1,944
| +14% | +$30.1K | ﹤0.01% | 4319 |
|
|
2018
Q1 | $168K | Sell |
13,983
-1,000
| -7% | -$10.8K | ﹤0.01% | 4419 |
|
|
2017
Q4 | $114K | Sell |
14,983
-56,039
| -79% | -$461K | ﹤0.01% | 4743 |
|
|
2017
Q3 | $567K | Buy |
+71,022
| New | +$551K | ﹤0.01% | 3699 |
|
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Royal Bank of Canada's ZYME Position: Q1 2026 in Review
Royal Bank of Canada reduced its Zymeworks (ZYME) stake by 14% in Q1 2026, selling an estimated $182K and leaving 47,360 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3496.
Royal Bank of Canada first reported a position in ZYME in Q3 2017 and has held it in 33 quarters since. The position peaked at $1.84M in Q4 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Royal Bank of Canada held 47,360 shares of Zymeworks worth $1.19M as of Q1 2026.
- Royal Bank of Canada sold 7,695 Zymeworks shares in Q1 2026, an estimated $182K.
- Zymeworks made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3496 holding.
- Royal Bank of Canada first reported a position in Zymeworks in Q3 2017 and has held it in 33 quarters since.
- Royal Bank of Canada's Zymeworks position peaked at $1.84M in Q4 2020.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.